TAPPI Over The Wire Paper 360
Past Issues | Printer Friendly | TAPPI.org | Advertise | Buyers Guide | Travels with Larry Archive FacebookTwitterLinkedIn
       

Ten Toscotec Tissue Machines Now Running at Vinda’s Sanjiang Mill in China

Print Print this Article | Send to Colleague


Vinda Paper (China) Co., at its Sanjiang mill, Jiangmen, has started up two new Toscotec (Lucca, Italy) machines, TM 9 and TM 10. Both machines are AHEAD-2.0M, with a design speed of 1,800 m/min. TM 10 is the 21st machine supplied by Toscotec to Vinda.
 
Vinda’s Sanjiang mill in Guangdong province now has 10 Toscotec tissue machines of different models and configurations. Considering the startups of TM 9 and TM 10, the Chinese producer has achieved startup of all 10 machines in less than four years. This is a testament to the outstanding growth and sustained progress of the Vinda Group, and to Toscotec’s strategic development of customized design and state-of-the-art solutions for energy reduction. 

Furthermore, on June 20, Vinda Paper (Shandong) Co. fired up one AHEAD-1.5M ES tissue machine, which is already running at the speed of 1,500 m/min. The machine, which is the fourth installed in the Shandong mill, has a design speed of 1,700 m/min. and a net web width of 3,400 mm. The AHEAD-1.5M tissue machine has Toscotec’s second generation Steel Yankee Dryer TT SYD, steam-heated hoods, and a large suction press roll (with a diameter of 1,425 mm). Based on the remarkable results of previous projects, Vinda Group has once again chosen to invest in Toscotec’s tissue machine technology, which benefits from a comprehensive energy-saving concept—the TT DOES (Drying Optimization for Energy Saving) package. 

Apart from TM 4, Vinda’s Shandong mill hosts three other Toscotec-supplied machines: TM1 & 2 are AHEAD-1.5S ES, steadily running at 1,500 m/min and TM 3, identical to TM 4, started up last November, is now running at 1,600 m/min.
 
Vinda Group’s production capacity has now exceeded 1 million metric tpy.
 
 

 

Back to TAPPI: Over The Wire

Share Share on Facebook Share on Twitter Share on LinkedIn